Everolimus pharmacokinetics and its exposure–toxicity relationship in patients with thyroid cancer
Crossref DOI link: https://doi.org/10.1007/s00280-016-3050-6
Published Online: 2016-05-11
Published Print: 2016-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
de Wit, D.
Schneider, T. C.
Moes, D. J. A. R.
Roozen, C. F. M.
den Hartigh, J.
Gelderblom, H.
Guchelaar, H. J.
van der Hoeven, J. J.
Links, T. P.
Kapiteijn, E.
van Erp, N. P.
Funding for this research was provided by:
Novartis
License valid from 2016-05-11